Quantification of damages in post-M&A disputes under Swiss law | International Financial Law Review iflr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iflr.com Daily Mail and Mail on Sunday newspapers.
To embed, copy and paste the code into your website or blog:
In the first appellate decision relating to Certificates of Supplementary Protection (CSPs), the Federal Court of Appeal has allowed the appeal of the Minister of Health (the Minister), setting aside the lower court judgment.
In a unanimous decision released on April 14, 2021, the Federal Court of Appeal in
Canada (Health) v Glaxosmithkline Biologicals S.A., 2021 FCA 71 found that the Federal Court (see article here) did not correctly apply the applicable standard of review.
The Decision Under Review
The Minister had found that
SHRINGIX contained only one medicinal ingredient a Varicella Zoster Virus (VZV) gE antigen, and that the adjuvant in SHINGRIX was not a medicinal ingredient.
Cryptocurrency Tax Data Requests: It s Easier To Go Fishing In Canada forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Article content
The head of Canada’s largest uranium miner says he is both “delighted” and “frustrated” after its latest victory in a multi-billion-dollar dispute with the federal government’s taxation authority.
The Supreme Court of Canada announced Thursday morning that it will not hear the Canada Revenue Agency’s appeal in its case against Cameco Corp. over billions of dollars in disputed income.
We apologize, but this video has failed to load.
Try refreshing your browser, or Cameco delighted and frustrated after latest victory in CRA case Back to video
“(It is) vindicating for our employees and Cameco after a 13-year battle with the CRA. Pleased about that,” said Tim Gitzel, the Saskatoon-based company’s CEO.
potential claims by exclusive distributors against importers of grey market goods.
Other major developments included:
the Trademark Office s issue of new limits on extensions of time for responding to an office action; and
the availability of expedited examination for trademark applications where the goods or services are for the prevention or treatment of COVID-19.
This article revisits these notable cases and developments and considers their implications for 2021.
Case law developments in 2020
Comparative advertising
In one of the first notable decisions of 2020, the Federal Court considered the legal limits to comparative advertising under the Competition Act and the Trademarks Act in